SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
JFK's granddaughter Tatiana Schlossberg reveals terminal cancer diagnosis - 2How mountain terraces have helped Indigenous peoples live with climate uncertainty
- 3How did birds survive while dinosaurs went extinct?
- 4Flu cases are rising with a strain that makes older people sicker
- 5Which camera do you believe is great for first-time clients? !
- Step by step instructions to Remain Spurred While Chasing after a Web-based Degree
- Congress is running out of time to extend ACA subsidies as the GOP moves on to an alternative plan. Here's where things stand.
- Interoceanic Train derails in southern Mexico, injuring at least 15 and halting traffic on line
- Holiday season sees uptick in norovirus cases, according to CDC
- Flu surges across U.S. as doctor visits reach highest level since 1997
- How grandchildren are stepping up to fill the caregiver gap
- Exhaustive Experiences into Prudent Senior Living in the UK
- The Secret Side of Italy: 12 Underrated Destinations Locals Don’t Want Tourists to Find
- 3D Printers for Specialists
